P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 3, 2011, Pages 423-429

  Lucattelli, Monica ^b   Cicko, Sanja ^a   Müller, Tobias ^a   Lommatzsch, Marek ^c   De Cunto, Giovanna ^b   Cardini, Silvia ^b   Sundas, William ^b   Grimm, Melanie ^a   Zeiser, Robert ^a   Dürk, Thorsten ^a   Zissel, Gernot ^a   Sorichter, Stephan ^a   Ferrari, Davide ^d   Di Virgilio, Francesco ^d   Virchow, J Christian ^c   Lungarella, Giuseppe ^b   Idzko, Marco ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

ATP; Cigarette smoke induced lung inflammation; Emphysema; P2x7 receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; CIGARETTE SMOKE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; PURINERGIC P2X7 RECEPTOR;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IN VIVO STUDY; KNOCKOUT MOUSE; LUNG ALVEOLUS MACROPHAGE; LUNG EMPHYSEMA; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; RECEPTOR UPREGULATION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; EMPHYSEMA; FLOW CYTOMETRY; HUMAN; INFLAMMATION; LUNG LAVAGE; METABOLISM; METHODOLOGY; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKE; SMOKING;

ANIMALIA; MUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; EMPHYSEMA; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, PURINERGIC P2X7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOKE; SMOKING;

EID: 79952218099     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0038OC     Document Type: Article

References (33)

1. Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006.AmJ RespirCrit Care Med 2007;175:1222-1232.
2. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653. (Pubitemid 38787999)
3. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22:672-688. (Pubitemid 37258549)
4. O'Donnell R, Breen D, Wilson S, Djukanovic R. Inflammatory cells in the airways in COPD. Thorax 2006;61:448-454. (Pubitemid 43723331)
5. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-721. (Pubitemid 39140629)
6. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 59-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006;112:358-404. (Pubitemid 44486409)
7. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 2006;58:58-86.
8. Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003;64:785-795. (Pubitemid 37153046)
9. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 1997;185:153-163. (Pubitemid 27039449)
10. Mohsenin A, Blackburn MR. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2006;12:54-59. (Pubitemid 44378579)
11. Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 2008;118:3301-3315.
12. Mortaz E, Braber S, Nazary M, Givi ME, Nijkamp FP, Folkerts G. ATP in the pathogenesis of lung emphysema. Eur J Pharmacol 2009;619:92-96.
13. Lommatzsch M, Cicko S, Müller T, Lucattelli M, Bratke K, Stoll P, Grimm M, Dürk T, Zissel G, Ferrari D, et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:928-934.
14. Chen Y, Shukla A, Namiki S, Insel PA, Junger WG. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J Leukoc Biol 2004;76:245-253. (Pubitemid 38857193)
15. Meshki J, Tuluc F, Bredetean O, Ding Z, Kunapuli SP. Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. Am J Physiol 2004;286:C264-C271. (Pubitemid 38146350)
16. Verghese MW, Kneisler TB, Boucheron JA. P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J Biol Chem 1996;271:15597-15601. (Pubitemid 26225333)
17. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG. ATPrelease guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006;314:1792-1795. (Pubitemid 44969094)
18. Inoue Y, Chen Y, Hirsh MI, Yip L, Junger WG. A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis. Shock 2008;30:173-177.
19. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001;97:587-600. (Pubitemid 32113390)
20. 2+ increases and cytokine secretion. J Immunol 2008;181:2181-2188.
21. Gu BJ, Wiley JS. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 2006;107:4946-4953. (Pubitemid 43882649)
22. Murphy JK, Livingston FR, Gozal E, Torres M, Forman HJ. Stimulation of the rat alveolar macrophage respiratory burst by extracellular adenine nucleotides. Am J Respir Cell Mol Biol 1993;9:505-510. (Pubitemid 2007510)
23. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M, Richardson J, Peck WL, et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005;114:386-396. (Pubitemid 40385877)
24. Cavarra E, Lucattelli M, Gambelli F, Bartalesi B, Fineschi S, Szarka A, Giannerini F, Martorana PA, Lungarella G. Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress. Am J Physiol 2001;281:L412-L417.
25. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007;13:913-919. (Pubitemid 47222044)
26. Reutershan J, Basit A, Galkina EV, Ley K. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol 2005;289:L807-L815. (Pubitemid 41504412)
27. Martorana PA, Beume R, Lucattelli M, Wollin L, Lungarella G. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am J Respir Crit Care Med 2005;172:848-853. (Pubitemid 41369068)
28. Hyman MC, Petrovic-Djergovic D, Visovatti SH, Liao H, Yanamadala S, Bouis D, et al. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 2009;119:1136-1149.
29. Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumor necrosis factor-a drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004;170:492-498. (Pubitemid 39209129)
30. Stevenson CS, Coote K, Webster R, Johnston H, Atherton HC, Nicholls A, Giddings J, Sugar R, Jackson A, Press NJ, et al. Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am J Physiol 2005;288:L514-L522. (Pubitemid 40229517)
31. Kellerman D, Rossi Mospan A, Engels J, Schaberg A, Gorden J, Smiley L. Denufosol: a review of studies with inhaled P2Y(2) agonists that led to phase 3. Pulm Pharmacol Ther 2008;21:600-607.
32. 7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 2001;166:6754-6763.
33. Tuluc F, Bredetean O, Brailoiu E, Meshki J, Garcia A, Dun NJ, Kunapuli SP. The priming effect of extracellular UTP on human neutrophils: role of calcium released from thapsigargin-sensitive intracellular stores. Purinergic Signal 2005;1:359-368. (Pubitemid 43019534)